Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) FCF Margin (2022 - 2025)

Envoy Medical's FCF Margin history spans 4 years, with the latest figure at 10428.57% for Q3 2025.

  • For Q3 2025, FCF Margin fell 400893.0% year-over-year to 10428.57%; the TTM value through Sep 2025 reached 8235.1%, up 95123.0%, while the annual FY2024 figure was 8412.89%, 295593.0% down from the prior year.
  • FCF Margin for Q3 2025 was 10428.57% at Envoy Medical, down from 5719.23% in the prior quarter.
  • Across five years, FCF Margin topped out at 1296.25% in Q3 2023 and bottomed at 12100.0% in Q4 2022.
  • The 4-year median for FCF Margin is 8110.87% (2025), against an average of 7752.69%.
  • The largest annual shift saw FCF Margin skyrocketed 1051222bps in 2023 before it tumbled -771589bps in 2024.
  • A 4-year view of FCF Margin shows it stood at 12100.0% in 2022, then grew by 3bps to 11753.68% in 2023, then grew by 8bps to 10850.0% in 2024, then rose by 4bps to 10428.57% in 2025.
  • Per Business Quant, the three most recent readings for COCH's FCF Margin are 10428.57% (Q3 2025), 5719.23% (Q2 2025), and 8110.87% (Q1 2025).